Indasi Lifescience Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
as on 03-12-2024
- Paid Up Capital ₹ 1.81 Cr
as on 03-12-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.88 Cr
as on 03-12-2024
- Satisfied Charges ₹ 14.12 Cr
as on 03-12-2024
- Revenue 40.28%
(FY 2022)
- Profit 56.88%
(FY 2022)
- Ebitda 65.68%
(FY 2022)
- Net Worth 105.66%
(FY 2022)
- Total Assets 25.22%
(FY 2022)
About Indasi Lifescience
The Corporate was formerly known as Bliss Indasi Lifescience Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 1.81 Cr.
The company currently has active open charges totaling ₹10.88 Cr. The company has closed loans amounting to ₹14.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hasmukhbhai Patel, Ravindrakumar Singh, and Vikash Singh serve as directors at the Company.
- CIN/LLPIN
U24230DD2011PTC004692
- Company No.
004692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Daman, Daman & Diu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Indasi Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikash Singh  | Whole-Time Director | 09-Mar-2011 | Current |
| Ravindrakumar Singh | Director | 09-Mar-2011 | Current |
| Hasmukhbhai Patel | Director | 09-Mar-2011 | Current |
Financial Performance of Indasi Lifescience.
Indasi Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.28% increase. The company also saw a substantial improvement in profitability, with a 56.88% increase in profit. The company's net worth Soared by an impressive increase of 105.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indasi Lifescience?
In 2022, Indasi Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arihantanam Lifecare Private LimitedActive 14 years 6 monthsHasmukhbhai Patel and Ravindrakumar Singh are mutual person
Arihant Chemist (Varanasi) Private LimitedActive 4 months 22 daysRavindrakumar Singh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Jan 2024 | ₹0.70 M | Open |
Hdfc Bank Limited Creation Date: 08 Jan 2024 | ₹0.70 M | Open |
Axis Bank Limited Creation Date: 27 Oct 2023 | ₹6.00 M | Open |
How Many Employees Work at Indasi Lifescience?
Indasi Lifescience has a workforce of 207 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indasi Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indasi Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
